Literature DB >> 9551678

Reduction in hepatic cytochrome P-450 is correlated to the degree of liver fat content in animal models of steatosis in the absence of inflammation.

I Leclercq1, Y Horsmans, J P Desager, N Delzenne, A P Geubel.   

Abstract

BACKGROUND/AIM: Fatty liver has been associated with an increased risk of primary graft non-function and drug toxicity. However, these effects have been observed mainly in fatty liver with inflammation, a situation characterized by an overall reduction in cytochrome P-450 (CYP)-dependent activities as well as a contrasting increase in CYP2E1 activity. Our aim was to examine the impact of liver-fat accumulation on CYP in two animal models of fatty liver without necroinflammation.
METHODS: Ducks were force-fed with a high-glucidic diet and male Wistar rats, after 48 h fasting, were refed a high-glucidic, fat-free diet for 48 h. Total CYP, aminopyrine- (AND), erythromycin-N-demethylase (END) and chlorzoxazone hydroxylase (CZOHase) activities as well as CYP2E1 and CYP3A proteins were quantified on microsomal proteins.
RESULTS: Livers from force-fed ducks exhibited significant decreases in total CYP, AND, END and CZOHase activities, inversely correlated with fat-liver content. Refeeding male Wistar rats a high-glucidic, fat-free diet after 48 h fasting, resulting in a 235% increased liver fat content, was associated with a decrease in total CYP (55%), AND (78%), END (55%) and CZOHase (62%) activities as well as in CYP3A (70%) and CYP2E1 (80%) protein content. A significant inverse correlation was observed between CYP and total lipid content.
CONCLUSIONS: In these models of steatosis induced by nutritional manipulations, fat liver accumulation was associated with a significant decrease in CYP activities and in CYP protein expression. Furthermore, the decreases in both CYP content and related activities were correlated with the degree of liver fat content.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9551678     DOI: 10.1016/s0168-8278(98)80314-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

Authors:  Lauren N Bell; Constance J Temm; Rashmil Saxena; Raj Vuppalanchi; Philip Schauer; Mordechai Rabinovitz; Alyssa Krasinskas; Naga Chalasani; Samer G Mattar
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

Review 2.  Drug metabolism alterations in nonalcoholic fatty liver disease.

Authors:  Matthew D Merrell; Nathan J Cherrington
Journal:  Drug Metab Rev       Date:  2011-05-25       Impact factor: 4.518

Review 3.  Pregnane X receptor and constitutive androstane receptor at the crossroads of drug metabolism and energy metabolism.

Authors:  Jie Gao; Wen Xie
Journal:  Drug Metab Dispos       Date:  2010-08-24       Impact factor: 3.922

4.  Hepatic CYP3A expression is attenuated in obese mice fed a high-fat diet.

Authors:  Kouichi Yoshinari; Shunsuke Takagi; Teruyasu Yoshimasa; Junko Sugatani; Masao Miwa
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

5.  Acetaminophen pharmacokinetics in children with nonalcoholic fatty liver disease.

Authors:  Nicole J Barshop; Edmund V Capparelli; Claude B Sirlin; Jeffrey B Schwimmer; Joel E Lavine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-02       Impact factor: 2.839

6.  Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?

Authors:  Roni Atalay; Süleyman Sayar; Fatma Gülçiçek Ayrancı; Şüheda Çakmak; İbrahim Halil Tanboğa; Levent Doğanay; Kamil Özdil
Journal:  Turk J Gastroenterol       Date:  2022-07       Impact factor: 1.555

7.  Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans.

Authors:  Zaiqi Wang; Stephen D Hall; Juan F Maya; Lang Li; Ali Asghar; J C Gorski
Journal:  Br J Clin Pharmacol       Date:  2003-01       Impact factor: 4.335

Review 8.  Body mass index and the efficacy of acid-mediating agents for GERD.

Authors:  Brian C Jacobson
Journal:  Dig Dis Sci       Date:  2008-07-16       Impact factor: 3.199

9.  Association between hepatic steatosis and entecavir treatment failure in Chinese patients with chronic hepatitis B.

Authors:  Xi Jin; Yi-peng Chen; Yi-da Yang; You-ming Li; Lin Zheng; Chuan-qing Xu
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

10.  Serum alanine transaminase total bilirubin concentrations predict CYP3A activity as measured by midazolam and 1'-hydroxylation.

Authors:  Rui He; Yuhong Li; Jinguang Ruan
Journal:  Med Sci Monit       Date:  2015-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.